STOCK TITAN

Werewolf Therapeutics, Inc. (HOWL) Free Cash Flow by Year

HOWL

Werewolf Therapeutics, Inc. recorded an outflow of $60.3M in free cash flow in fiscal year 2025. This represents a decrease of 6.8% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Werewolf Therapeutics, Inc. has filed alongside them.

FY2025 annual
Free Cash Flow -$60.3M
YoY -6.8%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

HOWL Free Cash Flow by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY25S-4FY24S-4FY2310-KFY2210-KFY2110-KFY2010-K
Free Cash Flow-$60.3M-6.8%-$56.4M-69.1%-$33.4M+24.5%-$44.2M-1.9%-$43.4M-126.1%-$19.2M

HOWL Free Cash Flow by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'26S-4Q1'26S-4Q4'25S-4Q3'2510-QQ2'25S-4Q1'25S-4Q4'24S-4Q3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Free Cash FlowN/AN/A-$11.0M+23.3%-$15.2M-21.6%-$15.2M-6.8%-$18.9M-23.0%-$14.4M-200.5%-$12.5M-67.8%-$14.2M-27.8%-$15.4M-53.1%-$4.8M+61.4%-$7.4M+54.8%

What free cash flow means

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.

More Werewolf Therapeutics, Inc. financials

Frequently Asked Questions

What was Werewolf Therapeutics, Inc.'s free cash flow in fiscal year 2025?

Werewolf Therapeutics, Inc. recorded an outflow of $60.3M in free cash flow in fiscal year 2025.

How fast is Werewolf Therapeutics, Inc.'s free cash flow growing?

Werewolf Therapeutics, Inc. (HOWL) free cash flow fell by 6.8% year over year, from -$56.4M to -$60.3M in fiscal year 2025.

How has Werewolf Therapeutics, Inc.'s free cash flow changed over the years?

Across the 6 fiscal years this page covers, Werewolf Therapeutics, Inc. (HOWL) free cash flow went from -$19.2M in fiscal year 2020 to -$60.3M in fiscal year 2025.

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Werewolf Therapeutics, Inc. (HOWL) reported on that line in every period on record.